François Rozet

14PUBLICATIONS

96CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersCancer diagnosisBiological physics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|May 26, 2026

Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.

|Feb 14, 2025

Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 Trial.

Nadine Houédé, Thierry Chevallier, François Audenet

|May 30, 2024

A collaborative review of the microsatellite instability/deficient mismatch repair phenotype in patients with upper tract urothelial carcinoma.

Pierre-Etienne Gabriel, Géraldine Cancel-Tassin, François Audenet

|Feb 19, 2024

Scoring system for prediction of overall survival in patients with renal cell carcinoma T3aN0M0.

Caio Vinícius Suartz, Maurício Dener Cordeiro, Paulo Afonso de Carvalho

|Jan 02, 2023

Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review.

Yanish Soorojebally, Yann Neuzillet, Mathieu Roumiguié

|Dec 03, 2022

A prospective descriptive 1-year study in France of all BCG therapy dispensations for non-muscle-invasive bladder cancer.

Yann Neuzillet, Priscilla Leon, Thomas Seisen

Pageof 3

Frequent Collaborators

Gwenaelle Gravis

Constance Thibault

Yohann Loriot

Mathieu Roumiguié

Priscilla Leon

Yves Allory

Alexandra Masson-Lecomte

1 joint publications

Wenhuo Hu

1 joint publications

Alex Penson

1 joint publications

Benjamin Gordon

Frequent Collaborators

Gwenaelle Gravis

Constance Thibault

Yohann Loriot

Mathieu Roumiguié